These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Stelazine therapy of patients with the paranoid form of schizophrenia]. GALENKO VE; KEL'MISHKEIT EG Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():269-75. PubMed ID: 13960318 [No Abstract] [Full Text] [Related]
3. PARANOID SCHIZOPHRENIA IN A PATIENT WITH KLINEFELTER'S SYNDROME. BOND IK; MARGULIESAI Can Psychiatr Assoc J; 1964 Oct; 9():439-43. PubMed ID: 14220862 [No Abstract] [Full Text] [Related]
4. Stelazine (trifluoperazine) a preliminary report on a clinical trial. MADGWICK JR; McNEILL DL; DRIVER M; PRESTON GC J Ment Sci; 1958 Oct; 104(437):1195-8. PubMed ID: 13621167 [No Abstract] [Full Text] [Related]
5. Striking effects of chlorpromazine treatment in paranoid schizophrenia. GERLE B Encephale; 1956; 45(4):687-90. PubMed ID: 13384285 [No Abstract] [Full Text] [Related]
6. A double-blind trial to investigate the effects of Thorazine (Largactil, chlorpromazine), Compazine (Stemetil, prochlorperazine) and Stelazine (trifluoperazine) in paranoid schizophrenia. WILSON IC; McKAY J; SANDIFER MG J Ment Sci; 1961 Jan; 107():90-9. PubMed ID: 13785665 [No Abstract] [Full Text] [Related]
7. Disturbed chronic psychotic patients: pilot trial of stelazine. FORRESTER ME Br Med J; 1958 Jul; 2(5088):90-1. PubMed ID: 13546657 [No Abstract] [Full Text] [Related]
8. [Results of treatment of paraphrenia and paranoia with largactil]. BILIKIEWICZ T; SULESTROWSKI W; WDOWIAK L Neurol Neurochir Psychiatr Pol; 1956; 6(6):655-67. PubMed ID: 13407816 [No Abstract] [Full Text] [Related]
9. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders]. Ozola MIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116 [No Abstract] [Full Text] [Related]
10. Preliminary observations on trifluoperazine in schizophrenia. TOLAN EJ; PEPPEL HH Am J Psychiatry; 1959 Apr; 115(10):935. PubMed ID: 13637262 [No Abstract] [Full Text] [Related]
11. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol. O'Brien CP; DiGiacomo JN; Webb W Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044 [TBL] [Abstract][Full Text] [Related]
12. Trifluoperazine in the treatment of chronic schizophrenics. BARSA JA; SAUNDERS JC; KLINE NS Am J Psychiatry; 1959 Mar; 115(9):812. PubMed ID: 13627261 [No Abstract] [Full Text] [Related]
13. Experience with trifluoperazine in 110 female schizophrenics. KRUSE W Am J Psychiatry; 1959 May; 115(11):1031. PubMed ID: 13637286 [No Abstract] [Full Text] [Related]
14. Paranoia--prognosis and treatment: a review. Ritzler BA Schizophr Bull; 1981; 7(4):710-28. PubMed ID: 7034193 [TBL] [Abstract][Full Text] [Related]
15. A COMPARISON OF SKF-7261 AND TRIFLUOPERAZINE (STELAZINE) IN THE TREATMENT OF CHRONIC SCHIZOPHRENIC PATIENTS. BISHOP MP; BUDDINGTON RW; ROBINSON WG; SILVA F J Neuropsychiatr; 1963 Oct; 4():28-32. PubMed ID: 14089790 [No Abstract] [Full Text] [Related]
16. Views on paranoia. Smith CH Ala Med; 1986 May; 55(11):44-7. PubMed ID: 3716953 [No Abstract] [Full Text] [Related]
17. Drug therapy of thought disorder in chronic paranoid schizophrenia: a longitudinal study. Wilson IC; Paulson GW; Sandifer MG Dis Nerv Syst; 1968 Aug; 29(8):550-1. PubMed ID: 4877898 [No Abstract] [Full Text] [Related]
18. Use of trifluoperazine in chronic Negro schizophrenics. SEXTON MC Am J Psychiatry; 1959 Mar; 115(9):821-2. PubMed ID: 13627269 [No Abstract] [Full Text] [Related]
20. A COMPARISON OF PARGYLINE AND TRANYLCYPROMINE WITH AND WITHOUT THE ADDITION OF TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY. SHARPLEY P; MENA A; SCHIELE BC; HEISTAD G Curr Ther Res Clin Exp; 1964 May; 6():344-52. PubMed ID: 14193764 [No Abstract] [Full Text] [Related] [Next] [New Search]